180 related articles for article (PubMed ID: 36672781)
61. Identification and validation of a novel prognostic circadian rhythm-related gene signature for stomach adenocarcinoma.
Qian L; Ding X; Fan X; Li S; Qiao Y; Zhang X; Li J
Chronobiol Int; 2023 Jun; 40(6):744-758. PubMed ID: 37122167
[TBL] [Abstract][Full Text] [Related]
62. Identification of novel key regulatory lncRNAs in gastric adenocarcinoma.
Razavi H; Katanforosh A
BMC Genomics; 2022 May; 23(1):352. PubMed ID: 35525925
[TBL] [Abstract][Full Text] [Related]
63. A New Strategy to Identify ceRNA-Based CCDC144NL-AS1/SERPINE1 Regulatory Axis as a Novel Prognostic Biomarker for Stomach Adenocarcinoma
Huang Z; Liu X; Wu C; Lu S; Antony S; Zhou W; Zhang J; Wu Z; Tan Y; Fan X; You L; Jing Z; Wu J
Front Oncol; 2021; 11():802727. PubMed ID: 35155200
[TBL] [Abstract][Full Text] [Related]
64. High Endothelin Receptor Type A Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Stomach Adenocarcinoma.
Yan Y; Nie K; Zheng J; Jiang X; Huang Y; Zheng Z; Wen Y; Li P
Cancer Manag Res; 2021; 13():5013-5026. PubMed ID: 34234547
[TBL] [Abstract][Full Text] [Related]
65. Assessment of
Zhu M; Cui H; Zhang L; Zhao K; Jia X; Jin H
Transl Cancer Res; 2022 Jan; 11(1):193-205. PubMed ID: 35261896
[TBL] [Abstract][Full Text] [Related]
66. Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma.
Liao T; Lu Y; Li W; Wang K; Zhang Y; Luo Z; Ju Y; Ouyang M
Front Genet; 2022; 13():794621. PubMed ID: 36313430
[No Abstract] [Full Text] [Related]
67. A comprehensive characterization of alternative splicing events related to prognosis and the tumor microenvironment in lung adenocarcinoma.
Ma S; Zhu J; Wang M; Han T; Zhu J; Jiang R; Jiang T
Ann Transl Med; 2022 Apr; 10(8):479. PubMed ID: 35571443
[TBL] [Abstract][Full Text] [Related]
68. Early B-cell factors involve in the tumorigenesis and predict the overall survival of gastric cancer.
Wang Q; Liang J; Hu X; Gu S; Xu Q; Yan J
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34100918
[TBL] [Abstract][Full Text] [Related]
69. A Multi-Omics Study on the Effect of Helicobacter Pylori-Related Genes in the Tumor Immunity on Stomach Adenocarcinoma.
Wu X; Jian A; Tang H; Liu W; Liu F; Liu S; Wu H
Front Cell Infect Microbiol; 2022; 12():880636. PubMed ID: 35619651
[TBL] [Abstract][Full Text] [Related]
70. A protein with broad functions: damage-specific DNA-binding protein 2.
Bao N; Han J; Zhou H
Mol Biol Rep; 2022 Dec; 49(12):12181-12192. PubMed ID: 36190612
[TBL] [Abstract][Full Text] [Related]
71. Clonal Architectures Predict Clinical Outcome in Gastric Adenocarcinoma Based on Genomic Variation, Tumor Evolution, and Heterogeneity.
Ren C; Wu C; Wang N; Lian C; Yang C
Cell Transplant; 2021; 30():963689721989606. PubMed ID: 33900127
[TBL] [Abstract][Full Text] [Related]
72. Identification of miRNA biomarkers for stomach adenocarcinoma.
Qian H; Cui N; Zhou Q; Zhang S
BMC Bioinformatics; 2022 May; 23(1):181. PubMed ID: 35578189
[TBL] [Abstract][Full Text] [Related]
73. Alternative splicing patterns reveal prognostic indicator in muscle-invasive bladder cancer.
AZhaTi B; Wu G; Zhan H; Liang W; Song Z; Lu L; Xie Q
World J Surg Oncol; 2022 Jul; 20(1):231. PubMed ID: 35820925
[TBL] [Abstract][Full Text] [Related]
74. Systematic analysis and prediction model construction of alternative splicing events in hepatocellular carcinoma: a study on the basis of large-scale spliceseq data from The Cancer Genome Atlas.
Yang L; He Y; Zhang Z; Wang W
PeerJ; 2019; 7():e8245. PubMed ID: 31844595
[TBL] [Abstract][Full Text] [Related]
75. Inhibition of ITGB1-DT expression delays the growth and migration of stomach adenocarcinoma and improves the prognosis of cancer patients using the bioinformatics and cell model analysis.
Jiang N; Guo Q; Luo Q
J Gastrointest Oncol; 2022 Apr; 13(2):615-629. PubMed ID: 35557569
[TBL] [Abstract][Full Text] [Related]
76. A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma.
Zhu L; Wang Z; Sun Y; Giamas G; Stebbing J; Yu Z; Peng L
Front Oncol; 2021; 11():778637. PubMed ID: 35004299
[TBL] [Abstract][Full Text] [Related]
77. CXCL2 acts as a prognostic biomarker and associated with immune infiltrates in stomach adenocarcinoma.
Zhang J; Hou W; Zuo J; Huang Z; Ding X; Bu X
Medicine (Baltimore); 2022 Oct; 101(42):e31096. PubMed ID: 36281171
[TBL] [Abstract][Full Text] [Related]
78. DDB2 (damaged-DNA binding protein 2) in nucleotide excision repair and DNA damage response.
Stoyanova T; Roy N; Kopanja D; Raychaudhuri P; Bagchi S
Cell Cycle; 2009 Dec; 8(24):4067-71. PubMed ID: 19923893
[TBL] [Abstract][Full Text] [Related]
79. Molecular Characteristics and Prognostic Role of MFAP2 in Stomach Adenocarcinoma.
Tang F; Hu C; Long Z; Liu Y; Li G
J Healthc Eng; 2022; 2022():1417238. PubMed ID: 35356627
[TBL] [Abstract][Full Text] [Related]
80. Constructing and Validating a Pyroptosis-Related Genes Prognostic Signature for Stomach Adenocarcinoma and Immune Infiltration: Potential Biomarkers for Predicting the Overall Survival.
Xu J; Chen K; Wei Z; Wu Z; Huang X; Cai M; Yuan K; Huang P; Zhang J; Wang S
J Oncol; 2022; 2022():3102743. PubMed ID: 36199800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]